These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 538408)

  • 21. Clinical and biochemical course of alcoholic liver disease following sudden discontinuation of alcoholic consumption.
    Marshall JB; Burnett DA; Zetterman RK; Sorrell MF
    Alcohol Clin Exp Res; 1983; 7(3):312-5. PubMed ID: 6353982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients.
    Dolman JM; Hawkes ND
    Alcohol Alcohol; 2005; 40(6):515-9. PubMed ID: 16103035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting clinical recovery from alcoholic liver disease.
    Patek AJ; Koff RS
    J Clin Gastroenterol; 1983 Aug; 5(4):303-6. PubMed ID: 6886350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoembryonic antigen (CEA) in patients with alcoholic liver diseases.
    Bell H; Orjasaeter H; Lange HF
    Scand J Gastroenterol; 1979; 14(3):273-9. PubMed ID: 441676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormally fucosylated haptoglobin as a marker for alcoholic liver disease but not excessive alcohol consumption or non-alcoholic liver disease.
    Chambers W; Thompson S; Skillen AW; Record CO; Turner GA
    Clin Chim Acta; 1993 Oct; 219(1-2):177-82. PubMed ID: 8306457
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of ethanol challenge on serum glycoproteins in alcoholic and non-alcoholic liver disease.
    Cobden I; Matthewson K; Carr WP; Dick WC; Record CO
    Alcohol Alcohol; 1987; 22(3):257-63. PubMed ID: 2441717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: a possible marker of alcoholic hepatitis.
    González-Quintela A; Mella C; Pérez LF; Abdulkader I; Caparrini AM; Lojo S
    Alcohol Clin Exp Res; 2000 Aug; 24(8):1222-6. PubMed ID: 10968661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis.
    Fletcher LM; Kwoh-Gain I; Powell EE; Powell LW; Halliday JW
    Hepatology; 1991 Mar; 13(3):455-9. PubMed ID: 1999316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease.
    DeVane CL; Laizure SC; Stewart JT; Kolts BE; Ryerson EG; Miller RL; Lai AA
    J Clin Psychopharmacol; 1990 Oct; 10(5):328-32. PubMed ID: 2124217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial.
    Kuffner EK; Dart RC; Bogdan GM; Hill RE; Casper E; Darton L
    Arch Intern Med; 2001 Oct; 161(18):2247-52. PubMed ID: 11575982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired acetaldehyde metabolism in patients with non-alcoholic liver disorders.
    Matthewson K; Al Mardini H; Bartlett K; Record CO
    Gut; 1986 Jul; 27(7):756-64. PubMed ID: 3732886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitrogen economy in alcoholic patients without liver disease.
    Bunout D; Petermann M; Ugarte G; Barrera G; Iturriaga H
    Metabolism; 1987 Jul; 36(7):651-3. PubMed ID: 3600279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease.
    Baldi E; Burra P; Plebani M; Salvagnini M
    Ital J Gastroenterol; 1993 Oct; 25(8):429-32. PubMed ID: 8286777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of ethanol and liver disease on sex hormones and hepatic oestrogen receptors in women.
    Becker U
    Dan Med Bull; 1993 Sep; 40(4):447-59. PubMed ID: 8222764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrectomy, lack of gastric first pass metabolism of ethanol and alcoholic liver disease. Results of a multicentre study.
    Frezza M; Buda A; Terpin MM; Aricò S; Benvenuti S; Burra P; Casini A; Iaquinto G; Manghisi OG; Pasquale L; Petruzzi J; Salvagnini M; Surrenti E; Tabone M; Zancanella L
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):243-8. PubMed ID: 9646216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of cordycepin-enriched Cordyceps militaris on alcoholic hepatotoxicity in Sprague-Dawley rats.
    Cha JY; Ahn HY; Cho YS; Je JY
    Food Chem Toxicol; 2013 Oct; 60():52-7. PubMed ID: 23876821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspartate aminotransferase-immunoglobulin complexes in patients with chronic liver disease.
    Tameda M; Shiraki K; Ooi K; Takase K; Kosaka Y; Nobori T; Tameda Y
    World J Gastroenterol; 2005 Mar; 11(10):1529-31. PubMed ID: 15770731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study.
    Kuffner EK; Green JL; Bogdan GM; Knox PC; Palmer RB; Heard K; Slattery JT; Dart RC
    BMC Med; 2007 May; 5():13. PubMed ID: 17537264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol intake, alcohol dehydrogenase genotypes, and liver damage and disease in the Danish general population.
    Tolstrup JS; Grønbaek M; Tybjaerg-Hansen A; Nordestgaard BG
    Am J Gastroenterol; 2009 Sep; 104(9):2182-8. PubMed ID: 19550411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in the rate of ethanol metabolism in recently drinking alcoholic and nondrinking subjects.
    Kater RM; Carulli N; Iber FL
    Am J Clin Nutr; 1969 Dec; 22(12):1608-17. PubMed ID: 5362487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.